Published on 10/9/2008 in the Prospect News PIPE Daily.
New Issue: OccuLogix sells $2.17 million of shares in private placement
By Devika Patel
Knoxville, Tenn., Oct. 9 - OccuLogix, Inc. settled a $2.17 million private placement of stock on Oct. 6, according to an 8-K filed Thursday with the Securities and Exchange Commission.
The company sold 21,730,000 common shares at $0.10 per share.
Boston-based OccuLogix develops ophthalmic devices to treat age-related eye diseases.
| Issuer: | OccuLogix, Inc.
|
| Issue: | Common stock
|
| Amount: | $2,173,000
|
| Shares: | 21,730,000
|
| Price: | $0.10
|
| Warrants: | No
|
| Announcement date: | Oct. 9
|
| Settlement date: | Oct. 6
|
| Stock symbol: | Nasdaq: OCCXD
|
| Stock price: | $2.25 at close Oct. 8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
